CN112592359A - Fluorescent probe for detecting concentration of 2, 6-pyridine calcium dicarboxylate and preparation method and application thereof - Google Patents
Fluorescent probe for detecting concentration of 2, 6-pyridine calcium dicarboxylate and preparation method and application thereof Download PDFInfo
- Publication number
- CN112592359A CN112592359A CN202011517732.XA CN202011517732A CN112592359A CN 112592359 A CN112592359 A CN 112592359A CN 202011517732 A CN202011517732 A CN 202011517732A CN 112592359 A CN112592359 A CN 112592359A
- Authority
- CN
- China
- Prior art keywords
- calcium
- fluorescent probe
- rare earth
- concentration
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 63
- 239000011575 calcium Substances 0.000 title claims abstract description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title abstract description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title abstract description 9
- 229960003722 doxycycline Drugs 0.000 claims abstract description 65
- 229910052761 rare earth metal Inorganic materials 0.000 claims abstract description 47
- WCPGOAHESUQATA-UHFFFAOYSA-L calcium;pyridine-2,6-dicarboxylate Chemical compound [Ca+2].[O-]C(=O)C1=CC=CC(C([O-])=O)=N1 WCPGOAHESUQATA-UHFFFAOYSA-L 0.000 claims abstract description 41
- BFVVOQCVYJQZPD-UHFFFAOYSA-N calcium;pyridine-2,6-dicarboxylic acid Chemical compound [Ca].OC(=O)C1=CC=CC(C(O)=O)=N1 BFVVOQCVYJQZPD-UHFFFAOYSA-N 0.000 claims abstract description 29
- -1 rare earth salt Chemical class 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002244 precipitate Substances 0.000 claims abstract description 13
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 claims abstract 4
- 238000002189 fluorescence spectrum Methods 0.000 claims description 12
- 229910052693 Europium Inorganic materials 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000002795 fluorescence method Methods 0.000 claims description 8
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 6
- 150000002910 rare earth metals Chemical group 0.000 claims description 6
- 238000001228 spectrum Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical group [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 claims description 3
- 238000003760 magnetic stirring Methods 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- 230000005284 excitation Effects 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 238000007185 Stork enamine alkylation reaction Methods 0.000 abstract description 2
- 238000006073 displacement reaction Methods 0.000 abstract description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 16
- 238000001514 detection method Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 241000193738 Bacillus anthracis Species 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000012921 fluorescence analysis Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000013110 organic ligand Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 229940072172 tetracycline antibiotic Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000001132 ultrasonic dispersion Methods 0.000 description 2
- MAYVZUQEFSJDHA-UHFFFAOYSA-N 1,5-bis(methylsulfanyl)naphthalene Chemical compound C1=CC=C2C(SC)=CC=CC2=C1SC MAYVZUQEFSJDHA-UHFFFAOYSA-N 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- NNMXSTWQJRPBJZ-UHFFFAOYSA-K europium(iii) chloride Chemical compound Cl[Eu](Cl)Cl NNMXSTWQJRPBJZ-UHFFFAOYSA-K 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002073 nanorod Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000004763 spore germination Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/182—Metal complexes of the rare earth metals, i.e. Sc, Y or lanthanide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention discloses a fluorescent probe for detecting the concentration of 2, 6-pyridinedicarboxylic acid calcium, a preparation method and application thereof. The fluorescent probe is a rare earth-doxycycline complex, and the specific method comprises the following steps: dissolving soluble rare earth salt and doxycycline in water to obtain a uniform solution containing rare earth elements; and (3) adjusting the pH value of the solution containing the rare earth elements to be alkalescent, generating precipitates at the moment, and continuing to react until the precipitates are not increased any more, thereby obtaining the rare earth-doxycycline complex fluorescent probe. The application is that the fluorescent probe is used for detecting the concentration of the 2, 6-pyridine calcium dicarboxylate solution. The invention innovatively coordinates doxycycline and rare earth ions, and the obtained rare earth-doxycycline complex has the advantages of long fluorescence life, stable luminescent signal, large Storkes displacement, narrow peak, avoidance of background interference of organisms, strong binding property with calcium 2, 6-pyridinedicarboxylate, capability of being used for detecting the concentration of calcium 2, 6-pyridinedicarboxylate, and popularization to other sensors for detecting the concentrations of different biological micromolecules.
Description
Technical Field
The invention belongs to the technical field of biosensing, and particularly relates to a fluorescent probe for detecting the concentration of 2, 6-pyridinedicarboxylic acid calcium, a preparation method and application thereof.
Background
Anthrax is used as a fulminant infectious disease, and the pathogen bacillus anthracis belongs to the second category of pathogenic microorganisms (highly pathogenic microorganisms) in the pathogenic microorganism catalogue of interpersonal infection published in China. During spore germination, 2, 6-dipicolinic acid (DPA) and divalent cations (mainly Ca) combined with the DPA account for about 5-10% of dry weight of spore2+) Therefore, the germination condition of the spores can be judged by detecting the unique marker of the calcium 2, 6-pyridinedicarboxylate, thereby indirectly achieving the effect of identifying the anthrax virus.
Many methods for detecting calcium 2, 6-pyridinedicarboxylate have been developed so far, including colorimetric analysis, polymerase chain reaction analysis, immunoassay, fourier transform infrared spectroscopy, gas chromatography, surface enhanced raman spectroscopy, high pressure liquid chromatography, electrochemical analysis, fluorescence analysis, and the like. Because other detection technologies are complex in implementation process, related instruments are expensive, and detection results cannot be directly observed, the fluorescence analysis method is widely applied due to the advantages of intuition and the like of the detection results.
The substrates for constructing the rare earth ion doping in the fluorescent probe mainly comprise inorganic materials and organic ligands. In the aspect of inorganic materials, research is mainly focused on rare earth doped carbon/silicon quantum dots and other small-scale nano materials. In the aspect of organic ligands, the design and synthesis of ligands such as oxygen-containing organic matters, nitrogen-containing organic matters, supermolecule macrocycles, biomolecules and the like are focused. Tetracycline antibiotics, as a class of rapid bacteriostats, have been widely used in veterinary medicine since their first discovery in 1950. Doxycycline is an excellent ligand of rare earth because of its molecular structure of beta-diketone, which is one of tetracycline antibiotics.
As natural hosts of the bacillus anthracis comprise herbivorous wild animals and livestock, the detection of the calcium 2, 6-pyridinedicarboxylate of meat products and milk products produced by the animals as raw materials requires a quick, green and nontoxic detection means. In addition, the detection reagent should have good water solubility. However, the existing fluorescent probe, whether a rare earth complex or a rare earth modified nano material, has the following disadvantages: the preparation steps are complex, reagents with different degrees of toxicity are required to participate in the preparation, and the water solubility is general.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a fluorescent probe for detecting the concentration of 2, 6-pyridinedicarboxylic acid calcium, a preparation method and application thereof.
The technical scheme for solving the technical problem of the fluorescent probe is to provide the fluorescent probe for detecting the concentration of the 2, 6-pyridinedicarboxylic acid calcium, and the fluorescent probe is characterized by being a rare earth-doxycycline complex.
The technical scheme for solving the technical problem of the method is to provide a preparation method of the fluorescent probe for detecting the concentration of the 2, 6-pyridinedicarboxylic acid calcium, which is characterized by comprising the following steps:
(1) dissolving soluble rare earth salt and doxycycline in water to obtain a uniform solution containing rare earth elements;
(2) and (3) adjusting the pH value of the solution containing the rare earth elements to be alkalescent, generating precipitates at the moment, and continuing to react until the precipitates are not increased any more, thereby obtaining the rare earth-doxycycline complex fluorescent probe.
The technical scheme for solving the application technical problem is to provide an application of the fluorescent probe for detecting the concentration of the 2, 6-pyridinedicarboxylic acid calcium, which is characterized in that the fluorescent probe is used for detecting the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution, and the specific steps are as follows:
(1) mixing the fluorescent probe with calcium 2, 6-dipicolinate solutions with different concentrations for reaction;
(2) measuring the spectrum by adopting a fluorescence method to obtain the fluorescence spectrum of the 2, 6-calcium dipicolinate solution with different concentrations;
(3) then, taking the concentration value of the calcium 2, 6-pyridinedicarboxylate as an abscissa, and taking the fluorescence intensity value of a characteristic peak in a fluorescence spectrum corresponding to different concentrations of the calcium 2, 6-pyridinedicarboxylate as an ordinate to draw a standard curve;
(4) and (3) measuring the fluorescence intensity of the 2, 6-pyridinedicarboxylic acid calcium solution with the concentration to be measured by a fluorescence method, and finding the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution corresponding to the fluorescence intensity in the standard curve to obtain the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution to be measured.
Compared with the prior art, the invention has the beneficial effects that:
1. the invention innovatively coordinates doxycycline and rare earth ions, and the obtained rare earth-doxycycline complex has the advantages of long fluorescence life, stable luminescent signal, large Storkes displacement, narrow peak, avoidance of background interference of organisms, strong binding property with calcium 2, 6-pyridinedicarboxylate, capability of being used for detecting the concentration of calcium 2, 6-pyridinedicarboxylate, and popularization to other sensors for detecting the concentrations of different biological micromolecules.
2. The molecular structure of doxycycline has multiple ketone carbonyl and hydroxyl functional groups, and such functional groups can realize ketol tautomerism under alkaline conditions, so as to generate free oxygen ions. Rare earth elements, on the other hand, tend to have a tendency toward negatively charged or neutral oxygen and nitrogen atoms due to their own high lewis acidity. Therefore, the rare earth ions can better form complexes with carbonyl oxygen in the doxycycline and oxygen anions in carboxylate ions.
3. The fluorescent probe is synthesized by a one-pot method, the preparation process is simple, the raw materials are nontoxic and easy to obtain, the price is low, the environment is friendly, and the method is suitable for popularization and application.
4. According to the method for quantitatively analyzing the concentration of the 2, 6-pyridinedicarboxylic acid calcium, the europium/dysprosium-doxycycline complex fluorescent probe is combined with the standard curve, so that the method is simple and convenient, the detection steps are simplified, other precise and expensive instruments are not needed, the cost is reduced, the slope of the standard curve can visually reflect the relative sensitivity of the fluorescent probe, and the higher the slope is, the higher the relative sensitivity is.
Drawings
FIG. 1 is a scanning electron micrograph of a europium-doxycycline complex prepared in example 1 of the present invention;
FIG. 2 is a fluorescence emission spectrum of europium-doxycycline complex obtained in example 1 of the present invention;
FIG. 3 is a fluorescence emission spectrum of europium-doxycycline complex in calcium 2, 6-pyridinedicarboxylate solutions of different concentrations according to example 1 of the present invention;
FIG. 4 is a standard curve diagram of the europium-doxycycline complex provided in example 1 of the present invention;
FIG. 5 is a scanning electron micrograph of dysprosium-doxycycline complex obtained in example 2 of the present invention;
FIG. 6 is a fluorescence emission spectrum of dysprosium-doxycycline complex obtained in example 2 of the present invention;
FIG. 7 is a fluorescence emission spectrum of dysprosium-doxycycline complex in calcium 2, 6-pyridinedicarboxylate solutions of different concentrations provided in example 2 of the present invention;
FIG. 8 is a graph of a calibration curve for dysprosium-doxycycline complexes provided in example 2 of the invention.
Detailed Description
Specific examples of the present invention are given below. The specific examples are only intended to illustrate the invention in further detail and do not limit the scope of protection of the claims of the present application.
The invention provides a fluorescent probe (called fluorescent probe for short) for detecting the concentration of 2, 6-pyridine calcium dicarboxylate, which is characterized in that the fluorescent probe is a rare earth-doxycycline complex.
Wherein the europium-doxycycline complex fluorescent probe is a 60nm nanorod particle, and the dysprosium-doxycycline complex fluorescent probe is in an amorphous state.
The invention also provides a preparation method (method for short) of the fluorescent probe for detecting the concentration of the 2, 6-pyridinedicarboxylic acid calcium, which is characterized by comprising the following steps:
(1) mixing soluble rare earth salt, doxycycline and water, and reacting for 0.5-1.5 h at 15-35 ℃ with stirring until the soluble rare earth salt and the doxycycline are dissolved in the water to obtain a uniform solution containing rare earth elements;
preferably, in step 1, the water is deionized water, distilled water or ultrapure water;
preferably, in step 1, the soluble rare earth salt is rare earth chloride or rare earth nitrate, and the rare earth element is dysprosium or europium;
preferably, in the step 1, the molar ratio of the soluble rare earth salt to the doxycycline is 1: 1-3; the ratio of the mol of the soluble rare earth salt to the volume of water is 1mol: 20-60L;
(2) and adjusting the pH value of the solution containing the rare earth elements to be alkaline (preferably alkalescence), allowing a tawny precipitate to appear, continuing to react for 0-5 hours under the stirring condition until the precipitate is not increased any more, and performing centrifugal separation, washing to remove impurities and drying to obtain the rare earth-doxycycline complex fluorescent probe.
Preferably, in the step 2, the alkalescence is 8-10; the method for adjusting the pH is to add ammonia water into the solution containing the rare earth elements, wherein the ammonia water has an alkaline effect.
Preferably, the stirring conditions in step 1 and step 2 are: magnetic stirring at a rotation speed of 200-800 r/min.
The invention also provides an application of the fluorescent probe, which is characterized in that the fluorescent probe is used for detecting the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution, and the specific steps are as follows:
(1) mixing the fluorescent probe with calcium 2, 6-dipicolinate solutions with different concentrations for reaction; the temperature of the mixing reaction is 15-35 ℃, and the time is 10-20 min;
(2) measuring the spectrum of 450-700 nm by adopting a fluorescence method to obtain the fluorescence spectrum of the 2, 6-calcium dipicolinate solution with different concentrations; the test conditions were: the spectra were measured in a fluorescence spectrometer with a voltage value of 700V, a scanning speed of 1200nm/min, a slit width of 10nm and an excitation wavelength of 340 nm.
(3) Then, taking the concentration value of the calcium 2, 6-pyridinedicarboxylate as an abscissa, and taking the fluorescence intensity value at the characteristic peak in the fluorescence spectrum corresponding to different concentrations of the calcium 2, 6-pyridinedicarboxylate as an ordinate, and drawing a standard curve similar to a straight line;
in the embodiment, 615nm of a europium-doxycycline complex fluorescent probe is a characteristic peak, and the fluorescence intensity changes along with the change of the concentration of calcium 2, 6-dipicolinate; the europium-doxycycline complex fluorescent probe is characterized by 480nm, and the fluorescence intensity changes along with the change of the concentration of the calcium 2, 6-pyridinedicarboxylate.
(4) And (3) measuring the fluorescence intensity of the 2, 6-pyridinedicarboxylic acid calcium solution with the concentration to be measured by a fluorescence method, and finding the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution corresponding to the fluorescence intensity in the standard curve to obtain the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution to be measured.
In the step 1), the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution is 1-100 mu M. The concentrations of the calcium 2, 6-pyridinedicarboxylate solutions corresponding to the europium-doxycycline complex fluorescent probe were 1. mu.M, 16. mu.M, 32. mu.M, 48. mu.M, 64. mu.M, 80. mu.M, and 100. mu.M. The concentrations of the 2, 6-dipicolinic acid calcium solution corresponding to the dysprosium-doxycycline complex fluorescent probe are 1 mu M, 20 mu M, 40 mu M, 60 mu M, 80 mu M and 100 mu M.
Under the assistance of an ultraviolet lamp, with the continuous increase of the concentration of the 2, 6-pyridine calcium dicarboxylate solution, the fluorescence of the rare earth-doxycycline complex fluorescent probe can be directly observed from weak to strong by eyes, wherein europium ions gradually change from colorless to red, and dysprosium ions gradually change from colorless to blue. Therefore, the europium/dysprosium-doxycycline complex fluorescent probe can be used for detecting the calcium 2, 6-pyridinedicarboxylate.
Example 1
(1) 0.5mmol of europium chloride (EuCl)3·6H2O,0.1382g) and 1mmol of doxycycline (C)22H24N2O80.18g) of the rare earth element is dissolved in 20mL of deionized water, and the solution is magnetically stirred for 40min at the room temperature under the condition that the rotating speed is 500r/min, so that uniform solution containing the rare earth element is obtained;
(2) adjusting the pH value of the solution containing the rare earth elements to 9 by using ammonia water, stirring and reacting for 2 hours under the condition that the rotating speed is 800r/min, centrifugally separating out precipitate under the condition that the rotating speed is 5000r/min, washing for 3 times by using absolute ethyl alcohol, and finally drying the separated precipitate in an oven at 60 ℃ for 24 hours to obtain the europium-doxycycline complex fluorescent probe.
As can be seen from FIG. 1, the europium-doxycycline complex fluorescent probe obtained in example 1 is a nano-rod-shaped particle with an average particle size of 60 nm.
As can be seen from FIG. 2, the europium-doxycycline complex obtained in example 1 has a peak at 615nmObvious characteristic peak corresponding to europium ion5D0→7F2The emission peak generated by the transition shows that the doxycycline and the rare earth europium ion are matched in energy level, and energy transfer exists between the doxycycline and the rare earth europium ion, namely the rare earth europium ion is successfully coordinated with the doxycycline.
The method for detecting the concentration of the 2, 6-pyridine calcium dicarboxylate solution by using the europium-doxycycline complex fluorescent probe comprises the following steps:
(1) 0.0053g (1.0X 10)-5mol) mixing the europium-doxycycline complex fluorescent probe with a 2, 6-pyridinedicarboxylic acid calcium solution with standard concentration to perform specific reaction, and performing ultrasonic dispersion for 10min to obtain a solution to be detected;
the concentrations of standard concentration 2, 6-pyridine calcium dicarboxylate solutions are respectively 1 muM, 16 muM, 32 muM, 48 muM, 64 muM, 80 muM and 100 muM, and the volumes are all 100 mL;
(2) respectively taking 3mL of the solution to be detected by a pipette, placing the solution to be detected into a cuvette one by one, and detecting an emission spectrum of the solution by using a fluorescence spectrometer under the condition that the monitoring wavelength is 340nm (shown in figure 3);
(3) and then, taking the concentration value of the standard concentration calcium 2, 6-pyridinedicarboxylate solution as an abscissa and taking the fluorescence intensity value at 615nm in the fluorescence spectrum corresponding to the standard concentration calcium 2, 6-pyridinedicarboxylate solution as an ordinate, and drawing a standard curve of the calcium 2, 6-pyridinedicarboxylate under the europium-doxycycline complex fluorescent probe (as shown in fig. 4).
As can be seen from FIG. 3, the emission peak (i.e., characteristic peak) at 615nm corresponds to Eu in the europium-doxycycline complex3+Of ions5D0→7F2The intensity of these emission peaks increases (in a proportional relationship) with the increase of the concentration of the calcium 2, 6-pyridinedicarboxylate solution, wherein the intensity of the emission peak at about 615nm increases with the concentration of the calcium 2, 6-pyridinedicarboxylate solution (at 1.0X 10)6mol/L to 1.0X 10-4In the mol/L range).
As can be seen from FIG. 4, the standard curve shows a substantially linear relationship, which indicates that the europium-doxycycline complex has a good selectivity for calcium 2, 6-pyridinedicarboxylate. And (3) measuring the fluorescence intensity of the 2, 6-pyridinedicarboxylic acid calcium solution with the concentration to be measured by a fluorescence method, and finding the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution corresponding to the fluorescence intensity in the standard curve to obtain the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution to be measured.
R in FIG. 42To determine the coefficients in statistics, the ratio at which all the variations in the dependent variables can be explained by the independent variables by regression relations.
Example 2
(1) Adding 0.5mmol dysprosium chloride (DyCl)3·6H2O,0.1435g) and 1mmol of doxycycline (C)22H24N2O80.18g) of the rare earth element is dissolved in 20mL of deionized water, and the solution is magnetically stirred for 40min at room temperature and the rotating speed of 500r/min to obtain a uniform solution containing the rare earth element;
(2) adjusting the pH value of the solution containing the rare earth elements to 9 by using ammonia water, stirring and reacting for 2 hours under the condition that the rotating speed is 800r/min, centrifugally separating out precipitate under the condition that the rotating speed is 5000r/min, washing for 3 times by using absolute ethyl alcohol, and finally drying the separated precipitate in an oven at 60 ℃ for 24 hours to obtain the dysprosium-doxycycline complex fluorescent probe.
As can be seen from FIG. 5, the dysprosium-doxycycline complex fluorescent probe obtained in example 2 is in an amorphous state.
As can be seen from FIG. 6, the dysprosium-doxycycline complex obtained in example 2 has a distinct characteristic peak at 480nm, which corresponds to dysprosium ion4F9/2→6H15/2The emission peak generated by the transition shows that the doxycycline and the rare earth dysprosium ions are matched in energy level, and energy transfer exists between the doxycycline and the rare earth dysprosium ions, namely the rare earth dysprosium ions are successfully coordinated with the doxycycline.
The method for detecting the concentration of the 2, 6-pyridine calcium dicarboxylate solution by the dysprosium-doxycycline complex fluorescent probe comprises the following steps:
(1) 0.0053g (1.0X 10)-5mol) mixing the dysprosium-doxycycline complex fluorescent probe with a 2, 6-pyridinedicarboxylic acid calcium solution with standard concentration to perform specific reaction, and performing ultrasonic dispersion for 10min to obtain a solution to be detected;
the concentrations of standard concentration 2, 6-pyridine calcium dicarboxylate solutions are respectively 1 muM, 20 muM, 40 muM, 60 muM, 80 muM and 100 muM, and the volumes are all 100 mL;
(2) respectively taking 3mL of the solution to be detected by a pipette, placing the solution to be detected into a cuvette one by one, and detecting an emission spectrum of the solution by using a fluorescence spectrometer under the condition that the monitoring wavelength is 340nm (as shown in figure 7);
(3) and then, taking the concentration value of the calcium 2, 6-pyridinedicarboxylate solution with the standard concentration as an abscissa and taking the fluorescence intensity value at 480nm in a fluorescence spectrum corresponding to the calcium 2, 6-pyridinedicarboxylate solution with the standard concentration as an ordinate, drawing a standard curve of the calcium 2, 6-pyridinedicarboxylate under the dysprosium-doxycycline complex fluorescent probe (as shown in FIG. 8).
As can be seen from FIG. 7, the emission peak (i.e., characteristic peak) at 480nm corresponds to Dy in the dysprosium-doxycycline complex3+Of ions4F9/2→6H15/2The intensity of these emission peaks increases (in a proportional relationship) with the increase of the concentration of the calcium 2, 6-pyridinedicarboxylate solution, wherein the intensity of the emission peak at about 480nm increases with the concentration of the calcium 2, 6-pyridinedicarboxylate solution (at 1.0X 10)6mol/L to 1.0X 10-4In the mol/L range).
As can be seen from FIG. 8, the standard curve shows a substantially linear relationship, which indicates that the dysprosium-doxycycline complex has good selectivity for calcium 2, 6-pyridinedicarboxylate. And (3) measuring the fluorescence intensity of the 2, 6-pyridinedicarboxylic acid calcium solution with the concentration to be measured by a fluorescence method, and finding the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution corresponding to the fluorescence intensity in the standard curve to obtain the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution to be measured.
In addition, the comparison of the slopes of the standard curves shows that compared with the europium-doxycycline complex fluorescent probe, the dysprosium-doxycycline complex has better detection sensitivity to calcium 2, 6-pyridinedicarboxylate.
Claims (10)
1. A fluorescent probe for detecting the concentration of 2, 6-pyridinedicarboxylic acid calcium is characterized in that the fluorescent probe is a rare earth-doxycycline complex.
2. A method for preparing a fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 1, comprising the steps of:
(1) dissolving soluble rare earth salt and doxycycline in water to obtain a uniform solution containing rare earth elements;
(2) and (3) adjusting the pH value of the solution containing the rare earth elements to be alkalescent, generating precipitates at the moment, and continuing to react until the precipitates are not increased any more, thereby obtaining the rare earth-doxycycline complex fluorescent probe.
3. The method for preparing a fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 2, wherein the mixing conditions in step 1 are: magnetic stirring is carried out for 0.5-1.5 h at the temperature of 15-35 ℃ and at the speed of 200-800 r/min.
4. The method for preparing a fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 2, wherein in step 1, the soluble rare earth salt is rare earth chloride or rare earth nitrate, and the rare earth element is dysprosium or europium.
5. The method for preparing a fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 2, wherein in step 1, the molar ratio of the soluble rare earth salt to doxycycline is 1: 1-3; the ratio of the mol of the soluble rare earth salt to the volume of the water is 1mol: 20-60L.
6. The method for preparing a fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 2, wherein in step 2, the weak base is pH 8 to 10.
7. The method for preparing a fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 2, wherein the reaction conditions in step 2 are: continuously reacting for 0-5 h under the condition of magnetic stirring at 200-800 r/min.
8. The method for preparing a fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 2, wherein in step 2, the rare earth-doxycycline complex fluorescent probe is obtained by centrifuging, washing to remove impurities, and drying after the precipitate is not increased any more.
9. The application of the fluorescent probe for detecting the concentration of the calcium 2, 6-pyridinedicarboxylate according to claim 1, is characterized in that the fluorescent probe is used for detecting the concentration of the calcium 2, 6-pyridinedicarboxylate solution, and the specific steps are as follows:
(1) mixing the fluorescent probe with calcium 2, 6-dipicolinate solutions with different concentrations for reaction;
(2) measuring the spectrum by adopting a fluorescence method to obtain the fluorescence spectrum of the 2, 6-calcium dipicolinate solution with different concentrations;
(3) then, taking the concentration value of the calcium 2, 6-pyridinedicarboxylate as an abscissa, and taking the fluorescence intensity value of a characteristic peak in a fluorescence spectrum corresponding to different concentrations of the calcium 2, 6-pyridinedicarboxylate as an ordinate to draw a standard curve;
(4) and (3) measuring the fluorescence intensity of the 2, 6-pyridinedicarboxylic acid calcium solution with the concentration to be measured by a fluorescence method, and finding the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution corresponding to the fluorescence intensity in the standard curve to obtain the concentration of the 2, 6-pyridinedicarboxylic acid calcium solution to be measured.
10. The application of the fluorescent probe for detecting the concentration of calcium 2, 6-pyridinedicarboxylate according to claim 9, characterized in that in step 1, the temperature of the mixing reaction is 15-35 ℃ and the time is 10-20 min; in step 2, the test conditions are as follows: measuring the spectrum of 450-700 nm in a fluorescence spectrometer with the voltage value of 700V, the scanning speed of 1200nm/min, the slit width of 10nm and the excitation wavelength of 340 nm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011517732.XA CN112592359B (en) | 2020-12-21 | 2020-12-21 | Fluorescent probe for detecting concentration of 2, 6-pyridinedicarboxylic acid calcium, preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011517732.XA CN112592359B (en) | 2020-12-21 | 2020-12-21 | Fluorescent probe for detecting concentration of 2, 6-pyridinedicarboxylic acid calcium, preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112592359A true CN112592359A (en) | 2021-04-02 |
CN112592359B CN112592359B (en) | 2022-05-03 |
Family
ID=75199608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011517732.XA Active CN112592359B (en) | 2020-12-21 | 2020-12-21 | Fluorescent probe for detecting concentration of 2, 6-pyridinedicarboxylic acid calcium, preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112592359B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114957679A (en) * | 2022-02-22 | 2022-08-30 | 中国科学院苏州生物医学工程技术研究所 | Metal organic framework material fluorescent probe and pyridine dicarboxylic acid detection method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106959290A (en) * | 2017-03-09 | 2017-07-18 | 华东师范大学 | A kind of Ratio-type rare-earth fluorescent probe and the application for detecting bacillus anthracis biomarker |
CN107954891A (en) * | 2017-12-15 | 2018-04-24 | 华南师范大学 | A kind of rare earth Tetracyclines complex and its preparation method and application |
CN110346338A (en) * | 2019-07-05 | 2019-10-18 | 中南大学 | A kind of fluorescence probe and preparation method thereof, biosensor and its construction method and application |
CN110903826A (en) * | 2019-12-20 | 2020-03-24 | 中南大学 | Fluorescent probe based on zeolite-based imidazole ester framework, preparation method thereof and application thereof in monitoring bacterial spore germination process |
-
2020
- 2020-12-21 CN CN202011517732.XA patent/CN112592359B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106959290A (en) * | 2017-03-09 | 2017-07-18 | 华东师范大学 | A kind of Ratio-type rare-earth fluorescent probe and the application for detecting bacillus anthracis biomarker |
CN107954891A (en) * | 2017-12-15 | 2018-04-24 | 华南师范大学 | A kind of rare earth Tetracyclines complex and its preparation method and application |
CN110346338A (en) * | 2019-07-05 | 2019-10-18 | 中南大学 | A kind of fluorescence probe and preparation method thereof, biosensor and its construction method and application |
CN110903826A (en) * | 2019-12-20 | 2020-03-24 | 中南大学 | Fluorescent probe based on zeolite-based imidazole ester framework, preparation method thereof and application thereof in monitoring bacterial spore germination process |
Non-Patent Citations (1)
Title |
---|
江虹 等: ""稀土与四环素类抗生素络合物的光度法研究"", 《分析化学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114957679A (en) * | 2022-02-22 | 2022-08-30 | 中国科学院苏州生物医学工程技术研究所 | Metal organic framework material fluorescent probe and pyridine dicarboxylic acid detection method |
CN114957679B (en) * | 2022-02-22 | 2023-09-05 | 中国科学院苏州生物医学工程技术研究所 | Metal organic framework material fluorescent probe and pyridine dicarboxylic acid detection method |
Also Published As
Publication number | Publication date |
---|---|
CN112592359B (en) | 2022-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107271409B (en) | Method for detecting metal ions in solution by using perovskite nanocrystal-based metal ion sensor | |
CN112898965B (en) | Preparation and use method of ratiometric fluorescent probe for visual differential detection | |
Ye et al. | Preparation of europium complex-conjugated carbon dots for ratiometric fluorescence detection of copper (II) ions | |
CN112816448A (en) | Fluorescence detection method for rapidly detecting tetracycline in food | |
CN114774118B (en) | Preparation and detection method of two-channel visual multicolor fluorescent probe | |
CN108949171B (en) | Rare earth carbon nano particle, preparation method thereof and application of rare earth carbon nano particle in determination of pH value based on fluorescence chromaticity | |
CN112592359B (en) | Fluorescent probe for detecting concentration of 2, 6-pyridinedicarboxylic acid calcium, preparation method and application | |
Weng et al. | Novel multi-component photofunctional nanohybrids for ratio-dependent oxygen sensing | |
CN109810256B (en) | Ternary heteronuclear metal organic framework luminescent material and preparation method and application thereof | |
CN110950854A (en) | Off-on molecular fluorescent probe CMTAH and preparation method and application thereof | |
CN112625676A (en) | Ratio type fluorescent carbon dot, preparation method thereof and method for detecting dopamine | |
CN113340862B (en) | Fluorescent molecular sensor, preparation method thereof and detection method of trace uranyl ions in water | |
CN110498930A (en) | A kind of preparation method and applications of Lanthanide Coordination Polymers nano material | |
CN110467570B (en) | Tetraphenylethylene-8-hydroxyquinoline compound and preparation method and application thereof | |
CN112500847A (en) | Cadmium ion probe based on quantum dot fluorescence resonance energy transfer system and preparation method thereof | |
CN101648908A (en) | New water-soluble rare-earth organic chelate fluorescent probe and preparation method thereof | |
CN113493473A (en) | High-efficiency red-light europium complex luminescent material and preparation method and application thereof | |
CN112759532B (en) | Reagent for visual rapid and sensitive detection of bacillus anthracis and detection method thereof | |
CN115433565B (en) | Preparation method of ratio type fluorescent probe for detecting nucleic acid amplification product | |
Feng et al. | Yu Wang | |
CN116925755B (en) | Preparation method of ferric ion doped carbon point, fluorescent probe and fluorescence detection method of indium ions | |
CN115109584B (en) | Be used for detecting dipicolinate and Cu2+Fluorescent nano probe composite material as well as preparation method and application thereof | |
CN116970116B (en) | Polymer copolymer containing coumarin-Tb complex, and preparation method and application thereof | |
CN117568027A (en) | Probe NGQD for detecting silver ions and formaldehyde based on ratio fluorescence and colorimetric method and preparation method thereof | |
CN118225746A (en) | Method for rapidly, simply, conveniently and highly sensitively quantitatively detecting tetracycline in water sample |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |